
ALERT!!
NEW FEATURE AVAILABLE – CHECK IT OUT: There is a new SHOW MARKUP button that allows you to view the manuals in a whole new way. Show or hide revisions in a section; the choice is yours. Go to any page within the manuals and use the new button now!
The Managed Care Support (MCS) Manuals (T-3) for contracts prior to 07/21/2016 are now superseded and can be found in the "Superseded" portion (indicated by a red banner) of each T-17 manuals' web page.
Other Services
Chapter 8
Section 16.1
Mucus
Clearance Devices
Issue Date: June 5, 1995
Revision: C-1, March 10, 2017
1.0 HCPCS PROCEDURE CODES
A7025, A7026, E0480 -
E0484, S8185
2.0 DESCRIPTION
2.1 Mucus
clearance devices are designed to clear mucus secretions from the
lungs of patients with mucociliary clearance impairment.
2.2 Some mucus clearance devices
resemble a combination of a smoker’s pipe and a referee’s whistle.
It consists of a hardened plastic mouthpiece at one end, a plastic
perforated cover at the opposite end, and a valve on the inside
created by a high-density stainless steel ball resting in a plastic circular
cone.
2.3 Other bronchial drainage systems
include an air oscillator and an inflatable vest and uses high-frequency
chest wall oscillations, which also clear mucus from the airway
wall. This type of system is a mechanical form of Chest Physical
Therapy (CPT) used as an alternative to conventional CPT in patients with
Cystic Fibrosis (CF).
3.0 POLICY
3.1 Mucus
clearance devices may be cost-shared for beneficiaries with mucus
producing lung diseases, including, but not limited to CF and Chronic
Obstructive Pulmonary Disease (COPD) (which encompasses both chronic
bronchitis and emphysema), and for beneficiaries with secretory impairment
that requires mucus clearance.
3.2 The mucus
clearance device used must be U.S. Food and Drug Administration
(FDA) approved. Coverage can only begin effective the date of FDA
approval.
3.3 Intrapulmonary
Percussive Ventilation (IPV) (Healthcare Common Procedure Coding
System (HCPCS) code E0481) may be considered for cost-sharing when
the diagnosis is CF.
- END -